Improving ECMO therapy with nitric oxide
Hospital Care

Improving ECMO therapy with nitric oxide

Although Extracorporeal Membrane Oxygenation (or ECMO) is a vital strategy to assist critically-ill patients survive, by providing the circulation of oxygen through the body, and is becoming an increasingly popular treatment across the globe, there are some severe complications that can arise with its use.

It has been found that during current ECMO treatments, as the patients’ blood is circulated outside of the body through the ECMO device and then pumped back into the body, the blood exposure to foreign materials and force of the blood moving through the blood vessels results in significant damage to blood cells and plasma proteins. This has also been shown to activate coagulatory (thickening of the blood) and inflammatory systems.

These complications can lead to a major reaction in the body and poor patient outcomes and a low survival rate. It is also seen that these harmful outcomes are again compounded by the current limitations in effective anti-coagulation therapies used ECMO.

The limitations of this life-saving therapy can lead to decreased confidence for its use – although it may still be the patient’s only hope. But, there is hope in some promising, yet limited, evidence indicating that nitric oxide may be an effective strategy for improved patient outcomes during and post-ECMO.

Professor John Fraser and his team are taking the challenge to investigate the potential benefits of introducing nitric oxide therapies to ECMO patients. They will be observing the abilities of nitric oxide across various markers such as its ability to: regulate blood cell and vessel geometry/activity, decreases platelet activation, regulate coagulation and its anti-oxidant properties helping to minimise inflammation.

The results of this study could change and enhance treatments for ECMO patients, greatly improve the success of ECMO and increase confidence in its use. Helping to save the lives of our most critically ill worldwide, with reduced risks.

Support The Common Good here

Published: April 26, 2019

Related news & events

What is a Giving Day?

The Common Good

What is a Giving Day?

What is a Giving Day? Giving days are becoming an increasingly popular way to fundraise. We explain what they are and the benefits.

Find out more

Grandfriends Ageless Play Program in Brisbane Expands

Aging

Grandfriends Ageless Play Program in Brisbane Expands

Grandfriends ageless play program in Brisbane expands thanks to support generated at The Common Good's 2022 Giving Day.

Find out more

Dementia Action Week 2023: ‘Act Now for a Dementia-Friendly Future’

Aging

Dementia Action Week 2023: ‘Act Now for a Dementia-Friendly Future’

Dementia Action Week 2023 runs from the 18th to the 24th of September: Dementia Australia is encouraging people to ‘act now for a dementia-friendly future’.

Find out more

Healing Ceilings Installed at Brisbane’s The Prince Charles Hospital

Hospital Care

Healing Ceilings Installed at Brisbane’s The Prince Charles Hospital

Some of the sickest patients in The Prince Charles Hospital’s thoracic ward can now look up and let their minds wander into nature, following the installation of Healing Ceilings.

Find out more

Include a Charity Week 2023: The Impact of Leaving a Gift in Will

The Common Good

Include a Charity Week 2023: The Impact of Leaving a Gift in Will

Have you heard of Include a Charity Week? Click here to read about the social change campaign and how you can have a lasting impact.

Find out more

What is Lung Disease?

Lung Disease

What is Lung Disease?

In this blog, we explain what lung disease is, discuss different types of lung disease and shed some light on common misconceptions.

Find out more

Ekka Strawberry Sundae Sales Records Tumble in 2023

The Common Good

Ekka Strawberry Sundae Sales Records Tumble in 2023

Ekka Strawberry Sundae Sales 2023: Sunny skies, soaring temps and support from showgoers all combined to create record-breaking sales.

Find out more

Idiopathic Pulmonary Fibrosis (IPF): What is it?

Lung Disease

Idiopathic Pulmonary Fibrosis (IPF): What is it?

Idiopathic Pulmonary Fibrosis is “a disease that afflicts many people at random.” Learn more about it in this blog.

Find out more

Bill Van Nierop: Life After Transplant

Lung Disease

Bill Van Nierop: Life After Transplant

Bill Van Nierop is incredibly grateful for the life-saving transplant he received. In this blog, we share more about Bill’s life and challenges he’s experienced after transplant.

Find out more